Literature DB >> 4037759

Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.

D L Arnold, D J Taylor, G K Radda.   

Abstract

Abnormal mitochondria are an increasingly recognized cause of neuromuscular disease. We have used phosphorus magnetic resonance spectroscopy to monitor noninvasively the metabolism of high-energy phosphates and the intracellular pH of human skeletal muscle in vivo in 12 patients with mitochondrial myopathy. At rest, an abnormality could be demonstrated in 11 of 12 patients. Ten patients had evidence of a reduced muscle energy state with at least one of the following abnormalities: low phosphorylation potential, low phosphocreatine concentration, high adenosine diphosphate concentration, or high inorganic phosphate concentration. Two patients had abnormal resting muscle intracellular pH. In some patients phosphocreatine concentration decreased to low values during exercise despite limited work output. This was not accompanied by particularly severe intracellular acidosis. Evidence of impaired rephosphorylation of adenosine diphosphate to adenosine triphosphate during recovery from exercise was found in approximately half the patients. Phosphorus magnetic resonance spectroscopy is useful in the noninvasive diagnosis of mitochondrial myopathies and in defining the pathophysiological basis of these disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037759     DOI: 10.1002/ana.410180205

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

1.  Magnetic resonance spectroscopy in congenital heart disease.

Authors:  V M Miall-Allen; G J Kemp; B Rajagopalan; D J Taylor; G K Radda; S G Haworth
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

2.  31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients.

Authors:  S F E Praet; H M M De Feyter; R A M Jonkers; K Nicolay; C van Pul; H Kuipers; L J C van Loon; J J Prompers
Journal:  MAGMA       Date:  2006-12-19       Impact factor: 2.310

3.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

Authors:  Tina Dysgaard Jeppesen; Bjørn Quistorff; Flemming Wibrand; John Vissing
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

Review 4.  Magnetic resonance spectroscopy in vivo: applications in neurological disorders.

Authors:  D L Arnold; N De Stefano
Journal:  Ital J Neurol Sci       Date:  1997-12

5.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

6.  Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy.

Authors:  B Barbiroli; R Medori; H J Tritschler; T Klopstock; P Seibel; H Reichmann; S Iotti; R Lodi; P Zaniol
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

7.  Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.

Authors:  T M Sinnwell; K Sivakumar; S Soueidan; C Jay; J A Frank; A C McLaughlin; M C Dalakas
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells.

Authors:  Oded Shaham; Nancy G Slate; Olga Goldberger; Qiuwei Xu; Arvind Ramanathan; Amanda L Souza; Clary B Clish; Katherine B Sims; Vamsi K Mootha
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

9.  Structural evidence for co-evolution of the regulation of contraction and energy production in skeletal muscle.

Authors:  Marina D Jeyasingham; Antonio Artigues; Owen W Nadeau; Gerald M Carlson
Journal:  J Mol Biol       Date:  2008-01-05       Impact factor: 5.469

10.  Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure.

Authors:  C H Thompson; R J Davies; G J Kemp; D J Taylor; G K Radda; B Rajagopalan
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.